Mostafa M. Kamal
2017
In 2017, Mostafa M. Kamal earned a total compensation of $1.6M as Chief Executive Officer Magellan Rx Management at Magellan Health, a 12% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $177,216 |
|---|---|
| Option Awards | $337,508 |
| Salary | $494,000 |
| Stock Awards | $520,033 |
| Other | $30,450 |
| Total | $1,559,207 |
Kamal received $520K in stock awards, accounting for 33% of the total pay in 2017.
Kamal also received $177.2K in non-equity incentive plan, $337.5K in option awards, $494K in salary and $30.5K in other compensation.
Rankings
In 2017, Mostafa M. Kamal's compensation ranked 6,778th out of 14,666 executives tracked by ExecPay. In other words, Kamal earned more than 53.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,778 out of 14,666 | 54th |
Division Services | 1,248 out of 2,424 | 49th |
Major group Health Services | 104 out of 224 | 54th |
Industry group Hospitals | 40 out of 57 | 30th |
Source: SEC filing on April 9, 2018.
Kamal's colleagues
We found four more compensation records of executives who worked with Mostafa M. Kamal at Magellan Health in 2017.